$PLTR

Analysts flag valuation concerns for $PLTR and $MU, projecting significant declines despite recent AI-driven gains.

Five technology stocks with 40%+ revenue growth—led by IonQ's 429% surge—position investors to benefit from AI infrastructure, quantum computing, and memory demand trends.

Anduril secured $99.6M Army contract for command and control prototypes, nearly four times Lockheed Martin's award, signaling potential shift toward emerging defense contractors ahead of its IPO.

Palantir stock surged 5.8% after federal court ruled ex-employees violated confidentiality by joining rival Percepta, protecting the company's proprietary AI data.

Five US stocks positioned to gain from geopolitical tensions: defense contractors Lockheed Martin, Northrop Grumman, RTX; energy firm ExxonMobil; and data analytics firm Palantir Technologies.

Palantir stock surges 10.8% as geopolitical tensions elevate its defense profile. Government contracts grew 66% YoY despite representing over 50% of domestic revenue.

Palantir surged 547% over five years but faces valuation scrutiny at 110x forward earnings. Strong Q4 growth and AI demand offer upside, though 26% recent pullback signals volatility ahead.

Palantir Technologies ($PLTR) delivers impressive 70% YoY revenue growth and 137% U.S. commercial growth, but 100x forward earnings valuation demands sustained excellence to justify current pricing.

Wall Street analysts issue sell ratings on Tesla and Palantir, citing severe overvaluations relative to business fundamentals and unrealistic growth assumptions.

Palantir's 56% revenue growth and 50% operating margin make it a superior AI investment compared to trendy prediction markets like Polymarket.

U.S. markets rose March 4 as President Trump backed crypto regulation. S&P 500 gained 0.78%, Nasdaq 1.29%, buoyed by stronger-than-expected jobs data.

Palantir jumped 4.3% on March 4, 2026, as Iran signaled de-escalation with U.S. and Israel, while Trump administration halted Anthropic government services, creating new federal contract opportunities for the defense tech firm.

$ONMD drops 11.5% after announcing AI-powered clinical data platform launch serving 2,130 healthcare sites with subscription model.

Analysis flags Rivian, Snowflake, Lucid, Palantir, DoorDash, Upstart, and Carvana as overvalued despite weak free cash flow generation, signaling potential volatility ahead.

Palantir surged 11% on strong earnings showing 70% revenue growth, but 80x sales valuation leaves little room for error. Analysts recommend waiting for better entry points.

Palantir surges 5.87% on strong Q4 with 56% revenue growth and $1B DHS contract, buoyed by defense AI demand amid geopolitical tensions.

Defense giants $LMT and $RTX hit all-time highs amid U.S.-Iran escalation. Trump signals 4-5 week campaign, raising conflict-of-interest questions over Congress members' stakes.

Palantir reports 70% revenue growth and 79% EPS growth with 137% commercial surge, though 100x P/E valuation leaves limited room for error amid recent 26% pullback.

Middle East tensions propelled energy and defense stocks while cruise lines tumbled Monday. Oil surged 5.1% to $70/barrel; Treasury yields jumped 11 basis points as markets repriced risk.

Wall Street analysts raise Palantir earnings estimates following strong Q4, targeting $196 stock price implying 43% upside, as company commands premium 183x earnings valuation.